Loading…
← CockpitCompetitor Analysis › 1515.HK China Resources Medical Holdings Co., Ltd.Open in the cockpit ↗

China Resources Medical Holdings Co., Ltd.1515.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Health Care›Hospital/Nursing Management
Momentum strong 66
Mkt cap
$393M
US dollars, full cap
Free float
63%
of shares outstanding
$/day
$388,270
20-day average traded
Fwd P/E
5.4×
forward earnings
ROIC−WACC
-3.3 pp
WACC 8.2%
Hurdle
-34 pp
Req g minus delivered
Next earnings
132 days
30 Mar 2027
Close · HKDHK$2.43
1D-2.0%
1W-5.6%
1M+2.1%
3M-7.2%
6M-9.7%
YTD-24.3%
1Y-28.3%
ATR %2.5%
52w lowhigh30.0% off high

What China Resources Medical does

Employees: 19,687

China Resources Medical at a glance

Size China Resources Medical (1515.HK) is a Hong Kong Health Care company (Hospital/Nursing Management) with a market value of $393M, the 819th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$2.43 on 18 Nov 2026.

Performance Over six months the shares fell 9.7%, against -3.4% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 7th lowest of 19 in its peer set.

Growth Revenue grew 0.4% over the last twelve months (peer median +11.9%); the operating margin is 5.9% (peer median 10.7%).

Valuation It trades at 5.4× forward earnings against a peer median of 22.5× (cheapest of 14).

Price implies For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is +26%, so the hurdle is -34 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 3.3 points below its cost of capital (8.2% WACC).

Next results Next results expected around 30 Mar 2027 (exchange calendar; dates can move).

Relative performance

9010011021 May 202621 Aug 202618 Nov 2026Peer median 951515.HK 92
Six months, rebased to 100: China Resources Medical against the median of its 20 peers (local-currency closes).

China Resources Medical financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$10.2BHK$9.95BHK$10.7BHK$11.2BHK$9.19B
Revenue growth—-7%-4%+22%—
Gross profitHK$1.40BHK$1.56BHK$1.96BHK$2.11BHK$1.52B
EBITDAHK$1.26BHK$1.09BHK$1.49BHK$1.56BHK$1.09B
Net incomeHK$473MHK$538MHK$614MHK$285MHK$309M
Free cash flowHK$767MHK$1.07BHK$702MHK$768MHK$435M
Capital expenditureHK$627MHK$554MHK$611MHK$538MHK$542M
Total debtn/aHK$950MHK$1.70BHK$2.54BHK$2.70B

Quarterly statements and history in the cockpit →

China Resources Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%+40%VOX60623012392609INDRAMEDCO301103VMDQC7GHCARTEMISMEDKOVAIHCGGDSJLHLRHKPARKHOSPS1515.HK6-month return →1-month return →
Up and to the right = strong over both horizons. China Resources Medical is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%+20%0×25×50×75×VOX6062301239INDRAMEDCOVMDQC7GHCARTEMISMEDHCGCBAVJLHLPARKHOSPS1515.HKRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. China Resources Medical is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%VOX60623012392609INDRAMEDCOKMCSHIL301103VMDQC7GHCARTEMISMEDKOVAIA50GDSCBAVPARKHOSPS1515.HKGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. China Resources Medical is the large dot.

China Resources Medical competitors and peer comparison

How China Resources Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

China Resources Medical against its 20 peers (data as of 18 Nov 2026)
Measure1515.HKPeer medianRank in peer set
1-month return+2.1%-2.1%10th highest of 20
6-month return-9.7%-3.4%7th lowest of 19
Distance from 52-week high-30.0%-18.4%8th lowest of 21
Revenue growth (TTM)+0.4%+11.9%2nd lowest of 21
Operating margin5.9%10.7%5th lowest of 21
Forward P/E5.4×22.5×cheapest of 14
Growth the price implies (Req g, 7 yrs)-7.5%7.2%least demanding of 17
Growth delivered (Del g)+26.3%+15.5%highest of 17
Hurdle (Req g minus delivered)-33.8 pp-4.9 ppleast demanding of 17
ROIC minus cost of capital-3.3 pp+1.1 pp5th lowest of 21
EV / EBITDA3.5×14.6×cheapest of 18
Net debt / EBITDA-0.2×0.6×4th least indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
China Resources Medical 1515.HKHong Kong$393M-10%0%6%5.4×-7.5%+26.3%
Voxel VOX.WAPoland$393M+59%+14%24%13.6×1.2%+12.2%
Charm Care 6062.TJapan$402M+57%+6%11%15.3×-0.4%+16.4%
Bright Eye Hospital 301239.SZChina$377M-26%+11%9%41.5×-5.1%+15.5%
Bayzed Health 2609.HKHong Kong$375M-58%-2%5%n/a14.7%+9.2%
Indraprastha Medical INDRAMEDCO.NSIndia$351M0%+11%15%15.9×14.9%+19.3%
KMC Speciality Hospitals (India) KMCSHIL.NSIndia$346Mn/a+35%23%n/a19.0%+24.4%
Liaoning He Eye Hospital 301103.SZChina$342M-20%+3%4%n/a-4.2%+5.4%
Viemed Healthcare VMDUnited States$333M-9%+22%8%17.4×6.8%+15.5%
Q & M Dental Group (Singapore) QC7.SISingapore$326M-26%+16%9%31.6×7.7%+7.5%
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%20.5×1.7%+18.3%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%

Questions

Which companies are China Resources Medical's closest peers?
The cockpit's peer set: Voxel (VOX.WA), Charm Care (6062.T), Bright Eye Hospital (301239.SZ), Bayzed Health (2609.HK), Indraprastha Medical (INDRAMEDCO.NS), KMC Speciality Hospitals (India) (KMCSHIL.NS), Liaoning He Eye Hospital (301103.SZ), Viemed Healthcare (VMD).
Is China Resources Medical expensive compared with its peers?
On forward p/e it trades at 5.4× against a peer median of 22.5×, cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is +26%, so the hurdle is -34 pp: the price already allows for a slowdown.
How has China Resources Medical stock performed?
Over six months to 18 Nov 2026 the shares returned -9.7% against -3.4% for the median peer; over one year -28.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.